Scholars Central

Research articlePublished 3 May 2019

Design, synthesis, docking and evolution of fused imidazoles as antiinflammatory and antibacterial agents

Authors: Galal A. M. Nawwar, Nabil M. Grant, Randa H. Swellem, Samia A. M. Elseginy

Der Pharma Chemica

Volume 5 · Issue 1 · Pages 241–255

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

New benzimidazole and imidzopyridine derivatives were designed and synthesized from their corresponding oximes II. The newly synthesized compounds were investigated in vivo for their anti-inflammatory and analgesic activities. Some of the new compounds (IVc, IVf, IVi) showed reasonable anti-inflammatory and analgesic activity in experimental rats in comparing to indomethacin and Diclofenac Na, as reference drugs Moreover, some of the newly synthesized compounds tested as antimicrobial agents, IVh exhibited potent antimicrobial activities with low MIC in comparing with Cefoperazone and Fluconazole as reference drugs Docking studies was carried out for derivatives of highest anti-inflammatory activity into the COX-2 binding site. Designed compounds IVc,IVf,IVi revealed a similar binding mode to COX-2 inhibitor.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharma Chemica.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharma Chemica
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Galal A. M. Nawwar”
  • BylineArticles whose byline prints “Nabil M. Grant”
  • BylineArticles whose byline prints “Randa H. Swellem”
  • BylineArticles whose byline prints “Samia A. M. Elseginy”